HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The anti-inflammatory actions of LCY-2-CHO, a carbazole analogue, in vascular smooth muscle cells.

Abstract
LCY-2-CHO has anti-inflammatory actions on macrophages. To understand its therapeutic implication in atherosclerosis, we examined its effects on the expressions of anti-inflammatory and inflammatory proteins in cultured rat aortic vascular smooth muscle cells (VSMC). LCY-2-CHO is able to induce heme oxygenase-1 (HO-1) protein expression through a transcriptional action. The HO-1 inducting effect of LCY-2-CHO was inhibited by SB203580, N(G)-nitro-l-arginine methylester (l-NAME), and wortmannin, but was not affected by U0126 or SP600125. In accordance LCY-2-CHO increased protein phosphorylation of p38, Akt, and eNOS. Nrf2 is a transcription factor essential for HO-1 gene induction and we showed that LCY-2-CHO is able to cause Nrf2 nuclear translocation and this action depends on p38, Akt and eNOS. In addition to induce anti-inflammatory HO-1, LCY-2-CHO reduced interleukin-1beta (IL-1beta)-induced inflammatory mediators, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), growth-related oncogene protein-alpha (GRO-alpha), and interleukin-8 (IL-8). Inhibitory effect on IL-1beta-mediated NF-kappaB activation was evidenced by the diminishment of IkappaB kinase (IKK) phosphorylation and IkappaBalpha degradation. In contrast, IL-1beta-mediated ERK and JNK activations were not changed by LCY-2-CHO, while p38 activation by IL-1beta and LCY-2-CHO displayed the non-additivity. Taken together, given the overall anti-inflammatory properties of LCY-2-CHO in VSMC, in terms to induce HO-1 gene expression and inhibit inflammatory gene expression, these results highlight the therapeutic potential of LCY-2-CHO in atherosclerosis.
AuthorsFeng-Ming Ho, Hao-Cheng Kang, Sho-Tone Lee, Yee Chao, You-Ci Chen, Li-Jiau Huang, Wan-Wan Lin
JournalBiochemical pharmacology (Biochem Pharmacol) Vol. 74 Issue 2 Pg. 298-308 (Jul 15 2007) ISSN: 0006-2952 [Print] England
PMID17499220 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 9-(2-chlorobenzyl)-9H-carbazole-3-carbaldehyde
  • Anti-Inflammatory Agents
  • Carbazoles
  • Chemokine CXCL1
  • Chemokines, CXC
  • Cxcl1 protein, rat
  • Interleukin-1beta
  • NF-E2-Related Factor 2
  • Nitric Oxide Synthase Type II
  • Heme Oxygenase (Decyclizing)
  • Hmox1 protein, rat
Topics
  • Active Transport, Cell Nucleus (drug effects)
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Carbazoles (pharmacology)
  • Cell Survival (drug effects)
  • Cells, Cultured
  • Chemokine CXCL1
  • Chemokines, CXC (biosynthesis)
  • Gene Expression Regulation (drug effects)
  • Heme Oxygenase (Decyclizing) (genetics)
  • Interleukin-1beta (pharmacology)
  • Muscle, Smooth, Vascular (cytology, drug effects, metabolism)
  • Myocytes, Smooth Muscle (drug effects, metabolism)
  • NF-E2-Related Factor 2 (metabolism)
  • Nitric Oxide Synthase Type II (biosynthesis)
  • Rats
  • Signal Transduction (drug effects)
  • Transcriptional Activation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: